Abivax (ABVX) Intangibles (2021 - 2026)
Abivax (ABVX) recorded quarterly Intangibles of $7.7 million in Q1 2026, up 0.58% quarter-over-quarter from $7.7 million in Q4 2025, and up 11.28% on a YoY basis from $6.9 million in Q1 2025.
Abivax (ABVX) Intangibles (2021 - 2026) Analysis & Trends
Abivax's Intangibles history runs 6 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Intangibles rose 11.28% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (up 11.28% YoY), while the FY2025 annual figure was $7.7 million, up 8.92% from the prior year.
- Intangibles was $7.7 million for Q1 2026 at Abivax, up from $7.7 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.7 million in Q1 2026 to a low of $6.7 million in Q4 2022.
- Historically, Intangibles has averaged $7.3 million across 5 years, with a median of $7.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Intangibles jumped 6235.95% in 2022, then fell 0.65% in 2024.
- A 5-year view of Intangibles shows it stood at $6.7 million in 2022, then gained by 5.41% to $7.1 million in 2023, then dropped by 0.65% to $7.1 million in 2024, then climbed by 8.92% to $7.7 million in 2025, then rose by 0.58% to $7.7 million in 2026.
- The last three Intangibles figures came in at $7.7 million (Q1 2026), $7.7 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.73 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Dec 31, 2022 | 6.74 Mn |
| Dec 31, 2021 | 106,389.30 |